These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25570853)

  • 1. BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data.
    Chen X; Shi X; Shajahan AN; Hilakivi-Clarke L; Clarke R; Xuan J
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():3937-40. PubMed ID: 25570853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification.
    Chen X; Shi X; Hilakivi-Clarke L; Shajahan-Haq AN; Clarke R; Xuan J
    Bioinformatics; 2017 Jan; 33(2):177-183. PubMed ID: 27659451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV-Bay: structural variant detection in cancer genomes using a Bayesian approach with correction for GC-content and read mappability.
    Iakovishina D; Janoueix-Lerosey I; Barillot E; Regnier M; Boeva V
    Bioinformatics; 2016 Apr; 32(7):984-92. PubMed ID: 26740523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood.
    Gyanchandani R; Kvam E; Heller R; Finehout E; Smith N; Kota K; Nelson JR; Griffin W; Puhalla S; Brufsky AM; Davidson NE; Lee AV
    Sci Rep; 2018 Nov; 8(1):17313. PubMed ID: 30470782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MosaicHunter: accurate detection of postzygotic single-nucleotide mosaicism through next-generation sequencing of unpaired, trio, and paired samples.
    Huang AY; Zhang Z; Ye AY; Dou Y; Yan L; Yang X; Zhang Y; Wei L
    Nucleic Acids Res; 2017 Jun; 45(10):e76. PubMed ID: 28132024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data.
    Ding J; Bashashati A; Roth A; Oloumi A; Tse K; Zeng T; Haffari G; Hirst M; Marra MA; Condon A; Aparicio S; Shah SP
    Bioinformatics; 2012 Jan; 28(2):167-75. PubMed ID: 22084253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local sequence assembly reveals a high-resolution profile of somatic structural variations in 97 cancer genomes.
    Zhuang J; Weng Z
    Nucleic Acids Res; 2015 Sep; 43(17):8146-56. PubMed ID: 26283183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of indels in next-generation sequencing data.
    Ratan A; Olson TL; Loughran TP; Miller W
    BMC Bioinformatics; 2015 Feb; 16(1):42. PubMed ID: 25879703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust and exact structural variation detection with paired-end and soft-clipped alignments: SoftSV compared with eight algorithms.
    Bartenhagen C; Dugas M
    Brief Bioinform; 2016 Jan; 17(1):51-62. PubMed ID: 25998133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.
    Hibsh D; Buetow KH; Yaari G; Efroni S
    Nucleic Acids Res; 2016 May; 44(9):e81. PubMed ID: 26809676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.
    Xi R; Lee S; Xia Y; Kim TM; Park PJ
    Nucleic Acids Res; 2016 Jul; 44(13):6274-86. PubMed ID: 27260798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
    Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
    BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.
    Baheti S; Tang X; O'Brien DR; Chia N; Roberts LR; Nelson H; Boughey JC; Wang L; Goetz MP; Kocher JA; Kalari KR
    BMC Bioinformatics; 2018 Jul; 19(1):271. PubMed ID: 30016933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RVD2: an ultra-sensitive variant detection model for low-depth heterogeneous next-generation sequencing data.
    He Y; Zhang F; Flaherty P
    Bioinformatics; 2015 Sep; 31(17):2785-93. PubMed ID: 25931517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data.
    Shiraishi Y; Sato Y; Chiba K; Okuno Y; Nagata Y; Yoshida K; Shiba N; Hayashi Y; Kume H; Homma Y; Sanada M; Ogawa S; Miyano S
    Nucleic Acids Res; 2013 Apr; 41(7):e89. PubMed ID: 23471004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples.
    Xiao C; Chen Z; Chen W; Padilla C; Colgan M; Wu W; Fang LT; Liu T; Yang Y; Schneider V; Wang C; Xiao W
    Genome Biol; 2022 Nov; 23(1):237. PubMed ID: 36352452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.